Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

NHS England

This public procurement record has 2 releases in its history.

Award

23 Aug 2024 at 10:12

Award Notice
Tender

11 Mar 2024 at 16:46

Tender Notice
Summary of the contracting process

The NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024, procured by NHS England, focuses on the supply of pharmaceutical products for retinal vascular treatments, including Anti Veg-F and Intravitreal Corticosteroid medicines. The procurement process is conducted under an open procedure and covers the period from 1 August 2024 to 31 July 2025, with options to extend up to 24 months. The contract, categorised under the pharmaceutical industry, aims to serve NHS England and other participating NHS bodies. Key suppliers awarded include Bayer plc, TEVA UK LIMITED, and Roche Products Limited, among others. Due to the significance of health-related services, interested parties were required to submit their bids by 10 April 2024, with the award period commencing on the same date.

This tender offers exceptional opportunities for businesses specialising in pharmaceutical products, particularly those involved in innovative treatments for retinal vascular conditions. Companies that can demonstrate robust supply chains, competitive pricing, and a comprehensive understanding of NHS procurement processes will find this framework highly lucrative. Given the substantial financial value and the strategic importance of the health sector, large pharmaceutical firms and SMEs with requisite capabilities are well-suited to participate. This can lead to significant business growth through contractual engagement with a major national health authority, enhanced market presence, and long-term partnerships within the public healthcare domain.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

Notice Description

Project title: NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024<br/>Offer reference number CM/PHS/24/5707 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.

Lot Information

Lot 1

The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04476f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/026978-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1,597,500,000 £1B-£10B
Lots Value
£1,597,500,000 £1B-£10B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
23 Aug 20242 years ago
Submission Deadline
10 Apr 2024Expired
Future Notice Date
Not specified
Award Date
25 Jul 20242 years ago
Contract Period
1 Aug 2024 - 31 Jul 2025 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
9
Supplier Names

Abbvie Ltd

Alimera Sciences

BIOGEN IDEC LIMITED

Bayer plc

NOVARTIS PHARMACEUTICALS UK LIMITED

Orion Pharma (UK) Ltd

ROCHE PRODUCTS LIMITED

TEVA UK LIMITED

Thornton and Ross Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...